Phoenix Molecular Imaging: Clinical Trials

3 trials sponsored by Phoenix Molecular Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1
Phase 31Withdrawn 1

Follow Phoenix Molecular Imaging: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
Sodium Acetate C11 PET/CT Imaging - Gliomas
Phase 2 / Phase 3WithdrawnPhoenix Molecular Imaging2014-05-012016-09-28
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
C11-Sodium Acetate - Prostate Cancer, Prostate Adenocarcinoma
Phase 2CompletedPhoenix Molecular Imaging3002012-04-012019-03-07
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
Sodium Acetate C11 - Prostate Cancer
Phase 2CompletedPhoenix Molecular Imaging20002011-04-012019-03-07

Conditions studied

Prostatic Neoplasms (2)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Recurrence (1)

Interventions

Carbon-11 (2)  ·  carbon-11 acetate (2)  ·  Magnetic Resonance Spectroscopy (1)

Countries

United States (3)

Top investigators

Fabio Almeida, MD (2)  ·  Fabio Almeida, M.D. (1)